N.

GSH

GST

GTK

CYP

 

 

nmol mg-1 of proteins

m

5

23.3±0.5

86.9±2.5

17.2±0.4

0.084±0.002

cm

5

23.2±1.8

85.5±2.6

17.6±0.3

0.023±0.005‡‡

m+t

5

26.9±0.6‡‡

99.6±2.2

27.3±0.7‡‡

0.084±0.001

cm+t

5

26.1±1.9

94.5±2.5

25.5±0.7‡‡

0.063±0.006*

m+e

5

37.0±0.7‡‡

59.0±3.4

18.4±0.3

0.026±0.006‡‡

cm+e

5

33.2±1.2‡‡

57.8±3.7

18.3±0.5

0.020±0.002‡‡

f

5

29.7±1.5a

64.1± 2.8b

17.8±0.3c

0.034±0.002d

cf

5

23.7±0.8‡‡

67.2±2.8

16.7±0.3***

0.029± 0.003

f+t

5

29.9±2.1

66.9±3.1

22.4±0.7‡‡

0.074±0.002‡‡

cf+t

5

24.7±0.6‡‡

61.5±3.2

22.9±0.7‡‡

0.052±0.005‡‡

f+e

5

34.9±0.6

54.3±1.2

18.2±0.3

0.018±0.003

cf+e

5

32.2±0.8

50.7±2.3#

18.3±0.3

0.026±0.002**

 

 

 

 

 

 

Legend: m= males, cm= castrated males; m+t= males treated with testosterone; cm+t= castrated males treated with testosterone; m+e= males treated with estradiol; cm+e= castrated males treated with estradiol; the same abbreviations were used for female (f); *p=0.0317; **p=0.0346; ***p=0.0397; #p=0.0173; p=0.0159; ‡‡p=0.0079. Superscript lowercase letters show significance of differences between genders: ap=0.0079, bp=0.0556 (not significant), cp=0.283 (not significant), dp=0.0079
Table 2: Kidney metabolism in male and females after castration, treatment with testosterone or estradiol, or castration and treatment with testosterone or estradiol. Results are supplied as mean ± standard error of the mean (SEM).